Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Availability Heuristic01:08

The Availability Heuristic

A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aligning Practice With Guidelines: A Canadian National Survey and Canadian Society of Nephrology Commentary on the 2025 KDIGO Pediatric Nephrotic Syndrome Recommendations.

Canadian journal of kidney health and disease·2026
Same author

Behaviour change techniques and physical activity outcomes in interventions for children with type 1 diabetes: A scoping review.

Diabetes research and clinical practice·2026
Same author

Addressing Care Partner Burden from the Underrecognition of Iatrogenic Sexual Behavior Changes in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Diagnostic approach to episodic ataxia types 1 and 2: a proposed algorithm for limited resource-settings.

Frontiers in neurology·2026
Same author

E3 ubiquitin ligases in neurodegenerative diseases.

Military Medical Research·2026
Same author

Clinical Predictors of Tic-Related Impairment in Children and Adults with Tourette Syndrome.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

A call for equity-informed pediatric palliative care in Canada.

Paediatrics & child health·2026
Same journal

Streamlining Kawasaki disease care: a quality improvement initiative to safely reduce length of stay.

Paediatrics & child health·2026
Same journal

La prise en charge de la dilatation des voies urinaires en période anténatale : un point de pratique clinique pour les prestataires de soins néonatals.

Paediatrics & child health·2026
Same journal

Proteinuria and gall bladder wall thickness as predictive indicators for dengue severity in pediatric patients.

Paediatrics & child health·2026
Same journal

Medical assistance in dying in pediatrics: a retrospective case study of clinical interactions and implications for team training.

Paediatrics & child health·2026
Same journal

Bill 79 and the search for truth for missing or deceased Indigenous children: Implications for paediatricians and the duty of memory.

Paediatrics & child health·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

[Not Available].

Josephine Ho1, Constadina Panagiotopoulos, Brian McCrindle

  • 1Département de pédiatrie, université de Calgary, Calgary (Alberta);

Paediatrics & Child Health
|October 2, 2013
PubMed
Summary
This summary is machine-generated.

This guideline offers evidence-based recommendations for managing metabolic complications in children using second-generation antipsychotics. It addresses weight gain, lipid and glucose abnormalities, and other issues to ensure safe and effective treatment.

Keywords:
Antipsychotic medicationsChildrenMetabolic syndrome

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

Related Experiment Videos

Last Updated: May 7, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

Area of Science:

  • Pediatric Endocrinology
  • Child and Adolescent Psychiatry
  • Clinical Pharmacology

Context:

  • Second-generation antipsychotics (SGAs) are increasingly prescribed for pediatric mental health conditions.
  • SGA use is linked to significant metabolic disturbances, necessitating careful monitoring.
  • Existing guidelines focus on monitoring; this work provides management strategies for identified complications.

Purpose:

  • To develop evidence-based recommendations for managing metabolic complications in pediatric patients treated with SGAs.
  • To support clinicians in addressing adverse metabolic effects associated with SGA therapy.
  • To provide a practical guide for the clinical management of SGA-induced metabolic issues.

Summary:

  • A systematic literature review and nominal group process were employed to formulate treatment recommendations.
  • Recommendations cover managing weight gain, increased waist circumference, and abnormal levels of prolactin, lipids, glucose, liver function, and thyroid hormones.
  • The guideline integrates existing recommendations for metabolic abnormalities in children.

Impact:

  • Facilitates proactive clinical management of metabolic side effects in children on SGAs.
  • Aims to improve the long-term health outcomes for pediatric patients undergoing antipsychotic treatment.
  • Enhances the safe and effective use of second-generation antipsychotics in pediatric populations.